Exactly because of the questions you are asking there should not have been a conference call to talk about meetings with MHRA and FDA. Just have the meetings and announce positive news if any and only report what is legally required.
Now expectations and speculation is set so high that nothing short of approval of some kind will support the price. For the record I don’t care about the daily ups and downs of the share price as I am looking longer term. However NPs actions show that he is not up to running the company. He is just winging it and hopefully we can get someone who can follow a proper business plan to bring Leronlimab to market.
B52T38.. I’m hoping for the British to offer help in conducting our Severe/ Critical Study in the U.K. Something our Government has not been willing to offer..
If the British start to help..Financially and Logically..Maybe..Just maybe..Our Warp Speed..FDA.. will look foolish enough in their own eyes..and BEGIN to REALLY look at us..!!!
News 
Market Data 
Discover 
AI
